Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Phase NA Recruiting
400 enrolled
NICHE
Recruiting
2,300 enrolled
DISCOVERY
Phase NA Recruiting
500 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
CAMPERR
Recruiting
7,000 enrolled
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
Phase NA Recruiting
196 enrolled
MAATEO
Phase 1 Recruiting
9 enrolled
Activity Levels in Bone Marrow Transplant Patients
Recruiting
200 enrolled
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
Recruiting
100 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Phase 2/3 Recruiting
900 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
Phase 2/3 Recruiting
900 enrolled
HALO-SCT
Recruiting
1,000 enrolled
ALHERT
Phase NA Recruiting
2,224 enrolled
HEME Home Transfusion Program
Phase NA Recruiting
700 enrolled
PROACTIVE
Phase NA Recruiting
88 enrolled
Mosaic
Phase NA Recruiting
356 enrolled
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Phase NA Recruiting
60 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
PALS_CT
Phase NA Recruiting
152 enrolled
PRONTO
Phase 2 Recruiting
100 enrolled
PEACE
Phase NA Recruiting
90 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
RATIONALISE
Phase 2/3 Recruiting
300 enrolled
ENROL
Recruiting
37,090 enrolled
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
Phase 1 Recruiting
10 enrolled
HemoDiag
Recruiting
500 enrolled